Company Filing History:
Years Active: 1997-2000
Title: Elwyn Peter Davies: Innovator in Pharmaceutical Chemistry
Introduction
Elwyn Peter Davies is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on proline derivatives. With a total of 8 patents to his name, Davies has established himself as a key figure in the development of therapeutic agents.
Latest Patents
Davies' latest patents focus on novel 1-substituted-N-[2-methyl-1-(trifluoroacetyl)propyl]pyrrolidine-2-carboxamide compounds. These compounds serve as inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE). The inhibition of HLE is crucial for various research applications in pharmacology and diagnostics, as well as in the treatment of diseases where HLE is implicated. His inventions also encompass pharmaceutical compositions containing these forms, along with processes for their preparation and intermediates useful in their synthesis.
Career Highlights
Elwyn Peter Davies is associated with Zeneca Limited, where he has contributed to groundbreaking research and development in the pharmaceutical sector. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options.
Collaborations
Davies has collaborated with notable colleagues, including Chris Allan Veale and Peter R Bernstein. These partnerships have enhanced the scope and impact of his research endeavors.
Conclusion
Elwyn Peter Davies is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of diseases. His innovative patents and collaborations continue to influence the field positively.